Identification of a Proposed Supplemental Rebate
Effective Mar 6, 2020Mass. Register #1412MGL c. 6D, § 8A MGL c. 118E, § 12AMassachusetts Health Policy Commission
- (1) Based on all available information, including information the Commission receives from MassHealth under M.G.L. c. 118E, § 12A, from the Referred Manufacturer under 958 CMR 12.04 and from any other interested stakeholders, the Commission may identify a proposed Supplemental Rebate for the Drug.
(2) In identifying a proposed Supplemental Rebate for the Drug, the Commission:
- (a) shall consult the Executive Office and take into consideration any proposed Supplemental Rebate framework previously introduced in negotiations between the Executive Office and the Referred Manufacturer;
- (b) may, as part of its consultation with the Executive Office, share information received from the Referred Manufacturer with the Executive Office; and
- (c) may base the proposed Supplemental Rebate on a proposed value of the Drug as identified by the Commission.